Skip to main content
Hit enter to search or ESC to close
Close Search
Menu
Company
Team
Psybrary™
Pipeline
Investors
Investor Overview
Press Releases
Media Coverage
Events + Presentations
Stock Information
SEC Filings
Corporate Governance
News Alerts
Contact
twitter
facebook
linkedin
Investors
Media Coverage
NASDAQ: ENVB
Overview
Press Releases
Media Coverage
Events + Presentations
Stock Information
SEC Filings
Corporate Governance
News Alerts
Media Coverage
Enveric Biosciences Hires Fish & Richardson to Defend Patent Tied to AbbVie Deal [Investing.com]
October 15, 2025
After the Billion-Dollar Psychedelic Bet: Who’s Next for Big Pharma? [Microdose]
October 10, 2025
How Enveric Biosciences Is Prepping For Its First IND [Clinical Leader]
October 10, 2025
The Next Chapter in Psychedelic Medicine: How Enveric Biosciences Stands Apart [HoneySuckle]
September 22, 2025
With big pharma circling psychedelics, the next breakthrough may not come from tripping at all [Microdose]
September 16, 2025
AbbVie’s $1B Psychedelic Bet: Who’s Next in the Neuroplastogen Gold Rush? [Microdose]
August 28, 2025
Reimagining Psychedelics: Mental Wellness Without the Roadblocks [Pharmaceutical Online]
August 19, 2025
Enveric Biosciences: Poised to Outshine Traditional Psychedelic Targets [Microdose]
August 18, 2025
The Future Of Psychedelic-Inspired Therapeutics: No-Trip Neuroplastogens [Life Science Leader]
August 14, 2025
Six psychedelic drug companies aiming to revolutionize mental health treatment [Labiotech]
August 12, 2025
‹
1
2
3
4
…
15
›
Close Menu
Company
Team
Psybrary™
Pipeline
Investors
Investor Overview
Press Releases
Media Coverage
Events + Presentations
Stock Information
SEC Filings
Corporate Governance
News Alerts
Contact
twitter
facebook
linkedin
